Previous studies have shown that multiple cancers were associated with overexpression of SP1, such as gastric cancer [20], pancreatic ductal adenocarcinoma [21], and lung cancer [22]. This evidence concerns the gene SP1 and pancreatic ductal adenocarcinoma.